Hamps Bio Limited (BSE SME)
December 13, 2024 – December 17, 2024
| Price | ₹51 - ₹51 |
| Premium | ₹60 |
|---|---|
| Lot size | 2000 |
| Allotment | Dec 18, 2024 |
| Listing | Dec 20, 2024 |
Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Subscription
Last updated on 17-Dec-2024 18:08:00
| Category | Offered | Applied | Times |
|---|---|---|---|
| HNIs | 578000 | 447032000 | 773.41 |
| Retail | 580000 | 777042000 | 1339.73 |
| Total | 1158000 | 1216140000 | 1050.21 |
| Total Applications: 665948 | |||
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹53 | @8% ₹60.5 | @9% ₹68.1 | @10% ₹75.6 | @11% ₹83.2 | @12% ₹90.8 |
About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 2000 | 102000 | 290 |
| HNI | 2 | 4000 | 204000 | 289 |
IPO Reservation
| Category | Shares Offered | No. of Shares |
|---|---|---|
| Retail | 47.5% | 580000 |
| Other | 47.4% | 578000 |
| Market Maker | 5.00% | 62000 |
| Total No. of Shares | 100.0% | 1220000 |
Hamps Bio IPO Details
| Issue Size | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Fresh Issue | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 3,136,000 |
| Share holding post issue | 4,356,000 |
| Market Maker portion | 62,000 shares |
| Market Maker | Pure Broking |
Key Performance Indicator
| KPI | Oct-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 16.65% | 21.14% | 30.31% |
| ROCE | 18.53% | 18.31% | 17.43% |
| RONW | 9.19% | 14.84% | 26.34% |
| D/E | 0.38 | 0.31 | 1.27 |
| EPS (basic) | 1.09 | 1.76 | 1.5 |
| P/E Pre IPO | 31.94 | ||
| P/E Post IPO | 38.03 |
Company Financials
Hamps Bio Limited Financial Information (Restated) In Lakhs.
| Period | Oct-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 644 | 515 | 396 | 364 |
| Revenue | 436 | 650 | 558 | 534 |
| Profit | 34 | 50 | 36 | 12 |
| Net Worth | 371 | 337 | 136 | 101 |
| Reserves | 57 | 141 | -14 | -49 |
| Borrowing | 138 | 105 | 174 | 204 |
About Company
Strength
Expert Leadership and Industry Experience: Seasoned management drives strategic growth and operational excellence.
Expansive Distribution Network with E-Retailing: Strong presence across 50+ distributors and leading e-commerce platforms like Amazon and Flipkart.
Diverse Product Portfolio: Offers over 180 products across pharmaceuticals and FMCG segments, catering to domestic and international markets.
Weakness
Outstanding Litigation: Pending legal cases could negatively impact our business, reputation, and financial performance if resolved unfavorably.
Dependence on Third-Party Manufacturing: Reliance on external manufacturers for pharmaceutical products poses supply and quality risks.
Single-Region Manufacturing Facility: The concentration of freeze-dried and frozen product manufacturing in Ankleshwar, Gujarat, makes operations vulnerable to regional disruptions.
Lead Manager(s)
Address
2900/112,
GIDC, Near Atul Limited,
Ankleshwar, Bharuch 393 002
Phone: +91 8000006663
Email: info@hampsbio.com
Website: http://www.hampsbio.com/